Facilitating Patient-Centered Decision Making Around the Timing of Direct-Acting Antivirals in Patients With Hepatitis C Virus and CKD

Abstract

S ince 2013, direct-acting antiviral (DAA) drugs have revolutionized the treatment of chronic hepatitis C virus (HCV) infection by offering relatively brief, welltolerated, and highly effective regimens. At the same